304 related articles for article (PubMed ID: 22730284)
1. In vivo flow cytometric Pig-a and micronucleus assays: highly sensitive discrimination of the carcinogen/noncarcinogen pair benzo(a)pyrene and pyrene using acute and repeated-dose designs.
Torous DK; Phonethepswath S; Avlasevich SL; Mereness J; Bryce SM; Bemis JC; Weller P; Bell S; Gleason C; Custer LL; MacGregor JT; Dertinger SD
Environ Mol Mutagen; 2012 Jul; 53(6):420-8. PubMed ID: 22730284
[TBL] [Abstract][Full Text] [Related]
2. Interlaboratory Pig-a gene mutation assay trial: Studies of 1,3-propane sultone with immunomagnetic enrichment of mutant erythrocytes.
Dertinger SD; Phonethepswath S; Weller P; Avlasevich S; Torous DK; Mereness JA; Bryce SM; Bemis JC; Bell S; Portugal S; Aylott M; MacGregor JT
Environ Mol Mutagen; 2011 Dec; 52(9):748-55. PubMed ID: 22052433
[TBL] [Abstract][Full Text] [Related]
3. Diethylnitrosamine genotoxicity evaluated in sprague dawley rats using pig-a mutation and reticulocyte micronucleus assays.
Avlasevich SL; Phonethepswath S; Labash C; Carlson K; Torous DK; Cottom J; Bemis JC; MacGregor JT; Dertinger SD
Environ Mol Mutagen; 2014 Jun; 55(5):400-6. PubMed ID: 24574022
[TBL] [Abstract][Full Text] [Related]
4. Assessment of genotoxicity induced by 7,12-dimethylbenz(a)anthracene or diethylnitrosamine in the Pig-a, micronucleus and Comet assays integrated into 28-day repeat dose studies.
Shi J; Krsmanovic L; Bruce S; Kelly T; Paranjpe M; Szabo K; Arevalo M; Atta-Safoh S; Debelie F; LaForce MK; Sly J; Springer S
Environ Mol Mutagen; 2011 Dec; 52(9):711-20. PubMed ID: 21976072
[TBL] [Abstract][Full Text] [Related]
5. Report on stage III Pig-a mutation assays using benzo[a]pyrene.
Bhalli JA; Shaddock JG; Pearce MG; Dobrovolsky VN; Cao X; Heflich RH; Vohr HW
Environ Mol Mutagen; 2011 Dec; 52(9):731-7. PubMed ID: 22052432
[TBL] [Abstract][Full Text] [Related]
6. Integration of Pig-a, micronucleus, chromosome aberration, and Comet assay endpoints in a 28-day rodent toxicity study with 4-nitroquinoline-1-oxide.
Stankowski LF; Roberts DJ; Chen H; Lawlor T; McKeon M; Murli H; Thakur A; Xu Y
Environ Mol Mutagen; 2011 Dec; 52(9):738-47. PubMed ID: 22020836
[TBL] [Abstract][Full Text] [Related]
7. Efficient monitoring of in vivo pig-a gene mutation and chromosomal damage: summary of 7 published studies and results from 11 new reference compounds.
Dertinger SD; Phonethepswath S; Avlasevich SL; Torous DK; Mereness J; Bryce SM; Bemis JC; Bell S; Weller P; Macgregor JT
Toxicol Sci; 2012 Dec; 130(2):328-48. PubMed ID: 22923490
[TBL] [Abstract][Full Text] [Related]
8. Mouse Pig-a and micronucleus assays respond to N-ethyl-N-nitrosourea, benzo[a]pyrene, and ethyl carbamate, but not pyrene or methyl carbamate.
Labash C; Avlasevich SL; Carlson K; Berg A; Torous DK; Bryce SM; Bemis JC; MacGregor JT; Dertinger SD
Environ Mol Mutagen; 2016 Jan; 57(1):28-40. PubMed ID: 26186091
[TBL] [Abstract][Full Text] [Related]
9. Pig-a gene mutation and micronucleated reticulocyte induction in rats exposed to tumorigenic doses of the leukemogenic agents chlorambucil, thiotepa, melphalan, and 1,3-propane sultone.
Dertinger SD; Phonethepswath S; Avlasevich SL; Torous DK; Mereness J; Cottom J; Bemis JC; Macgregor JT
Environ Mol Mutagen; 2014 May; 55(4):299-308. PubMed ID: 24449360
[TBL] [Abstract][Full Text] [Related]
10. International Pig-a gene mutation assay trial: evaluation of transferability across 14 laboratories.
Dertinger SD; Phonethepswath S; Weller P; Nicolette J; Murray J; Sonders P; Vohr HW; Shi J; Krsmanovic L; Gleason C; Custer L; Henwood A; Sweder K; Stankowski LF; Roberts DJ; Giddings A; Kenny J; Lynch AM; Defrain C; Nesslany F; van der Leede BJ; Van Doninck T; Schuermans A; Tanaka K; Hiwata Y; Tajima O; Wilde E; Elhajouji A; Gunther WC; Thiffeault CJ; Shutsky TJ; Fiedler RD; Kimoto T; Bhalli JA; Heflich RH; MacGregor JT
Environ Mol Mutagen; 2011 Dec; 52(9):690-8. PubMed ID: 21910140
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric analysis of Pig-a gene mutation and chromosomal damage induced by procarbazine hydrochloride in CD-1 mice.
Phonethepswath S; Avlasevich SL; Torous DK; Mereness J; Bemis JC; Macgregor JT; Dertinger SD
Environ Mol Mutagen; 2013 May; 54(4):294-8. PubMed ID: 23427001
[TBL] [Abstract][Full Text] [Related]
12. In vivo erythrocyte micronucleus assay III. Validation and regulatory acceptance of automated scoring and the use of rat peripheral blood reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level limit test.
Hayashi M; MacGregor JT; Gatehouse DG; Blakey DH; Dertinger SD; Abramsson-Zetterberg L; Krishna G; Morita T; Russo A; Asano N; Suzuki H; Ohyama W; Gibson D;
Mutat Res; 2007 Feb; 627(1):10-30. PubMed ID: 17157053
[TBL] [Abstract][Full Text] [Related]
13. Assessment of 5-fluorouracil and 4-nitroquinoline-1-oxide in vivo genotoxicity with Pig-a mutation and micronucleus endpoints.
Zhou C; Zhang M; Huang P; Tu H; Wang Z; Dertinger SD; Torous DK; Chang Y
Environ Mol Mutagen; 2014 Dec; 55(9):735-40. PubMed ID: 25124805
[TBL] [Abstract][Full Text] [Related]
14. Cyclophosphamide and etoposide canine studies demonstrate the cross-species potential of the flow cytometric peripheral blood micronucleated reticulocyte endpoint.
McKeon M; Xu Y; Kirkland D; Schmuck G; Krebsfänger N; Avlasevich SL; Dertinger SD
Mutat Res; 2012 Feb; 742(1-2):79-83. PubMed ID: 22227404
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Pig-a, micronucleus, and comet assay endpoints in a 28-day study with ethyl methanesulfonate.
Gunther WC; Coffing SL; Dickinson DA; Engel ME; Fiedler RD; O'Lone SD; Sanok KE; Thiffeault CJ; Shutsky TJ; Schuler MJ; Dobo KL
Environ Mol Mutagen; 2014 Jul; 55(6):492-9. PubMed ID: 24599777
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the Pig-a, micronucleus, and comet assay endpoints in rats treated by acute or repeated dosing protocols with procarbazine hydrochloride and ethyl carbamate.
Chen G; Wen H; Mao Z; Song J; Jiang H; Wang W; Yang Y; Miao Y; Wang C; Huang Z; Wang X
Environ Mol Mutagen; 2019 Jan; 60(1):56-71. PubMed ID: 30240497
[TBL] [Abstract][Full Text] [Related]
17. Pig-a mutation: kinetics in rat erythrocytes following exposure to five prototypical mutagens.
Phonethepswath S; Franklin D; Torous DK; Bryce SM; Bemis JC; Raja S; Avlasevich S; Weller P; Hyrien O; Palis J; Macgregor JT; Dertinger SD
Toxicol Sci; 2010 Mar; 114(1):59-70. PubMed ID: 19965957
[TBL] [Abstract][Full Text] [Related]
18. In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring.
Hayashi M; MacGregor JT; Gatehouse DG; Adler ID; Blakey DH; Dertinger SD; Krishna G; Morita T; Russo A; Sutou S
Environ Mol Mutagen; 2000; 35(3):234-52. PubMed ID: 10737958
[TBL] [Abstract][Full Text] [Related]
19. Integration of mutation and chromosomal damage endpoints into 28-day repeat dose toxicology studies.
Dertinger SD; Phonethepswath S; Franklin D; Weller P; Torous DK; Bryce SM; Avlasevich S; Bemis JC; Hyrien O; Palis J; MacGregor JT
Toxicol Sci; 2010 Jun; 115(2):401-11. PubMed ID: 20202993
[TBL] [Abstract][Full Text] [Related]
20. Interlaboratory validation of a CD71-based flow cytometric method (Microflow) for the scoring of micronucleated reticulocytes in mouse peripheral blood.
Torous DK; Hall NE; Illi-Love AH; Diehl MS; Cederbrant K; Sandelin K; Pontén I; Bolcsfoldi G; Ferguson LR; Pearson A; Majeska JB; Tarca JP; Hynes GM; Lynch AM; McNamee JP; Bellier PV; Parenteau M; Blakey D; Bayley J; van der Leede BJ; Vanparys P; Harbach PR; Zhao S; Filipunas AL; Johnson CW; Tometsko CR; Dertinger SD
Environ Mol Mutagen; 2005; 45(1):44-55. PubMed ID: 15605355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
